The latest closing stock price for InMed Pharmaceuticals as of March 07, 2025 is 2.73.
An investor who bought $1,000 worth of InMed Pharmaceuticals stock at the IPO in 2020 would have $-966 today, roughly -1 times their original investment - a -57.19% compound annual growth rate over 4 years.
The all-time high InMed Pharmaceuticals stock closing price was 133.75 on February 11, 2021.
The InMed Pharmaceuticals 52-week high stock price is 8.27, which is 202.9% above the current share price.
The InMed Pharmaceuticals 52-week low stock price is 0.12, which is 95.6% below the current share price.
The average InMed Pharmaceuticals stock price for the last 52 weeks is 1.43.
An investor who bought $1,000 worth of InMed Pharmaceuticals stock at the IPO in 2020 would have $-966 today, roughly -1 times their original investment - a -57.19% compound annual growth rate over 4 years.
The all-time high InMed Pharmaceuticals stock closing price was 133.75 on February 11, 2021.
The InMed Pharmaceuticals 52-week high stock price is 8.27, which is 202.9% above the current share price.
The InMed Pharmaceuticals 52-week low stock price is 0.12, which is 95.6% below the current share price.
The average InMed Pharmaceuticals stock price for the last 52 weeks is 1.43.